Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP
Abdulrahman Al-Mashdali, Hematology Chief Fellow at Hamad Medical Corporation, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Reviews:
“‘Targeting CD38 in Immune Thrombocytopenia: Rationale and a Scoping Review of Daratumumab’
In this review, we examine the emerging role of anti-CD38 therapy, particularly daratumumab, as a mechanistically distinct treatment strategy for patients with refractory or relapsed immune thrombocytopenia (ITP).
Current evidence suggests promising clinical responses, including rapid platelet recovery and durable remission in selected heavily pretreated patients.
Proud to contribute to this work alongside an outstanding team of collaborators Shehab Mohamed, Ayman Dalol.
Thank you to all my co-authors for their collaboration, expertise, and dedication throughout this project.
Published in Blood Reviews (Elsevier), a Q1 journal in Hematology with a 2025 Journal Impact Factor of 5.7.”
Title: Targeting CD38 in immune thrombocytopenia: Rationale and a scoping review of daratumumab
Authors: Abdulrahman F Al-Mashdali, Ayman Abdullah Dalol, Leen Haj Saleh, Ruba Adel Aweer, Mohammed Abdulgayoom, Honar Cherif, Shehab F Mohamed
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 07:35Anticoagulation and Contemporary Secondary Prevention of Thrombosis in Polycythemia Vera
-
Sep 5, 2026, 05:48Punit Mathur: From Leg Pain to Life-Threatening Pulmonary Embolism
-
Sep 5, 2026, 05:44Patrick Stonich: Identifying Missed Signs of Postoperative Pulmonary Embolism in Medical Record Reviews
-
Sep 5, 2026, 05:38Tom Van den Hoek: Warburg Effect Mimicking Refractory Shock in Cancer-Associated PE
-
Sep 5, 2026, 05:11Shinya Goto: Targeted Thrombolysis for High Risk Pulmonary Embolism
-
Sep 5, 2026, 04:56Opportunities for the Next Generation of Hematologists – American Society of Hematology
-
Sep 5, 2026, 04:51Samuel Nwokolo: The Bone Marrow Factory – Anatomy of Blood Production
-
Sep 5, 2026, 04:37Maryam Alaa Alsaid: Diagnostic Puzzle of Sickle Beta Thalassemia
-
Sep 5, 2026, 04:16Key Cardiovascular Insights from ESC Congress